FETNEURIA
LIVE

Serial Number

79378370

Owner

Telix Pharmaceuticals Limited

Filing Date

Aug 7, 2023

Add to watchlist:

No watchlists yet
View on USPTO

FETNEURIA Trademark

Serial Number: 79378370 • Registration: 7435769

FETNEURIA is a trademark filed by Telix Pharmaceuticals Limited on August 7, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

August 7, 2023

Registration Date

July 9, 2024

Published for Opposition

April 23, 2024

Goods & Services

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer

Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2026 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 8, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 8, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTICE OF PUBLICATION
Apr 3, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2024 CNSA
ASSIGNED TO EXAMINER
Mar 14, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 19, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 13, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 12, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 7, 2023 REPR